nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrimethamine—CYP2C8—Fenofibrate—coronary artery disease	0.0619	0.0837	CbGbCtD
Pyrimethamine—CYP2C8—Gemfibrozil—coronary artery disease	0.0495	0.0669	CbGbCtD
Pyrimethamine—CYP2C9—Fenofibrate—coronary artery disease	0.0432	0.0584	CbGbCtD
Pyrimethamine—CYP2C8—Clopidogrel—coronary artery disease	0.0429	0.058	CbGbCtD
Pyrimethamine—CYP2C8—Pitavastatin—coronary artery disease	0.0375	0.0507	CbGbCtD
Pyrimethamine—CYP2C9—Gemfibrozil—coronary artery disease	0.0345	0.0467	CbGbCtD
Pyrimethamine—CYP2C9—Clopidogrel—coronary artery disease	0.0299	0.0405	CbGbCtD
Pyrimethamine—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.0269	0.0364	CbGbCtD
Pyrimethamine—CYP2C9—Pitavastatin—coronary artery disease	0.0261	0.0354	CbGbCtD
Pyrimethamine—CYP2C8—Simvastatin—coronary artery disease	0.0257	0.0348	CbGbCtD
Pyrimethamine—CYP2C9—Valsartan—coronary artery disease	0.0254	0.0344	CbGbCtD
Pyrimethamine—CYP2C8—Lovastatin—coronary artery disease	0.0251	0.034	CbGbCtD
Pyrimethamine—CYP2C8—Pravastatin—coronary artery disease	0.0251	0.034	CbGbCtD
Pyrimethamine—CYP2C8—Atorvastatin—coronary artery disease	0.0229	0.031	CbGbCtD
Pyrimethamine—CYP2C8—Losartan—coronary artery disease	0.0209	0.0283	CbGbCtD
Pyrimethamine—CYP2D6—Niacin—coronary artery disease	0.0207	0.028	CbGbCtD
Pyrimethamine—CYP2C9—Rosuvastatin—coronary artery disease	0.0193	0.0261	CbGbCtD
Pyrimethamine—CYP2D6—Timolol—coronary artery disease	0.0193	0.0261	CbGbCtD
Pyrimethamine—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0188	0.0254	CbGbCtD
Pyrimethamine—CYP2C9—Simvastatin—coronary artery disease	0.0179	0.0242	CbGbCtD
Pyrimethamine—CYP2C9—Pravastatin—coronary artery disease	0.0175	0.0237	CbGbCtD
Pyrimethamine—CYP2C9—Lovastatin—coronary artery disease	0.0175	0.0237	CbGbCtD
Pyrimethamine—CYP2D6—Captopril—coronary artery disease	0.017	0.023	CbGbCtD
Pyrimethamine—CYP2D6—Simvastatin—coronary artery disease	0.0164	0.0222	CbGbCtD
Pyrimethamine—CYP2D6—Lovastatin—coronary artery disease	0.016	0.0217	CbGbCtD
Pyrimethamine—CYP2D6—Pravastatin—coronary artery disease	0.016	0.0217	CbGbCtD
Pyrimethamine—CYP2C9—Atorvastatin—coronary artery disease	0.016	0.0216	CbGbCtD
Pyrimethamine—CYP2C9—Losartan—coronary artery disease	0.0146	0.0198	CbGbCtD
Pyrimethamine—CYP2D6—Atorvastatin—coronary artery disease	0.0146	0.0198	CbGbCtD
Pyrimethamine—CYP2C9—cardial valve—coronary artery disease	0.00954	0.49	CbGeAlD
Pyrimethamine—Pulmonary eosinophilia—Trandolapril—coronary artery disease	0.00778	0.0512	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Enalapril—coronary artery disease	0.00775	0.051	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Captopril—coronary artery disease	0.00744	0.0489	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Perindopril—coronary artery disease	0.00722	0.0475	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Ramipril—coronary artery disease	0.00581	0.0382	CcSEcCtD
Pyrimethamine—Pulmonary eosinophilia—Lisinopril—coronary artery disease	0.00527	0.0347	CcSEcCtD
Pyrimethamine—Haematuria—Tirofiban—coronary artery disease	0.00205	0.0135	CcSEcCtD
Pyrimethamine—DHFR—cardiac ventricle—coronary artery disease	0.00182	0.0935	CbGeAlD
Pyrimethamine—DHFR—myocardium—coronary artery disease	0.00171	0.088	CbGeAlD
Pyrimethamine—Pancytopenia—Gemfibrozil—coronary artery disease	0.00138	0.00911	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Tirofiban—coronary artery disease	0.00137	0.00902	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Tirofiban—coronary artery disease	0.00134	0.00883	CcSEcCtD
Pyrimethamine—Haematuria—Ticagrelor—coronary artery disease	0.00121	0.00797	CcSEcCtD
Pyrimethamine—DHFR—heart—coronary artery disease	0.0012	0.0614	CbGeAlD
Pyrimethamine—Toxic epidermal necrolysis—Clopidogrel—coronary artery disease	0.00114	0.0075	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Lovastatin—coronary artery disease	0.00113	0.00745	CcSEcCtD
Pyrimethamine—DHFR—cardiovascular system—coronary artery disease	0.00113	0.0579	CbGeAlD
Pyrimethamine—Haematuria—Rosuvastatin—coronary artery disease	0.00109	0.00717	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Simvastatin—coronary artery disease	0.00106	0.00697	CcSEcCtD
Pyrimethamine—Pancytopenia—Clopidogrel—coronary artery disease	0.00104	0.00683	CcSEcCtD
Pyrimethamine—DHFR—cardiac atrium—coronary artery disease	0.00102	0.0525	CbGeAlD
Pyrimethamine—Hypersensitivity—Tirofiban—coronary artery disease	0.00101	0.00665	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Olmesartan—coronary artery disease	0.000995	0.00655	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Clopidogrel—coronary artery disease	0.000967	0.00636	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lovastatin—coronary artery disease	0.00096	0.00632	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Pravastatin—coronary artery disease	0.000957	0.0063	CcSEcCtD
Pyrimethamine—Haematuria—Clopidogrel—coronary artery disease	0.00093	0.00612	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Trandolapril—coronary artery disease	0.000929	0.00612	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Enalapril—coronary artery disease	0.000926	0.00609	CcSEcCtD
Pyrimethamine—Leukopenia—Gemfibrozil—coronary artery disease	0.000909	0.00598	CcSEcCtD
Pyrimethamine—Pancytopenia—Olmesartan—coronary artery disease	0.000907	0.00597	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Simvastatin—coronary artery disease	0.000898	0.00591	CcSEcCtD
Pyrimethamine—DHFR—blood—coronary artery disease	0.000892	0.0458	CbGeAlD
Pyrimethamine—Haematuria—Eplerenone—coronary artery disease	0.000886	0.00583	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pitavastatin—coronary artery disease	0.000862	0.00567	CcSEcCtD
Pyrimethamine—Pancytopenia—Trandolapril—coronary artery disease	0.000847	0.00557	CcSEcCtD
Pyrimethamine—Pancytopenia—Enalapril—coronary artery disease	0.000844	0.00555	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Furosemide—coronary artery disease	0.000838	0.00551	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Gemfibrozil—coronary artery disease	0.000829	0.00546	CcSEcCtD
Pyrimethamine—Erythema multiforme—Clopidogrel—coronary artery disease	0.000828	0.00545	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lovastatin—coronary artery disease	0.000822	0.00541	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Pravastatin—coronary artery disease	0.000812	0.00534	CcSEcCtD
Pyrimethamine—Haematuria—Olmesartan—coronary artery disease	0.000812	0.00534	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Gemfibrozil—coronary artery disease	0.000812	0.00534	CcSEcCtD
Pyrimethamine—Pancytopenia—Captopril—coronary artery disease	0.000809	0.00533	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Losartan—coronary artery disease	0.000808	0.00532	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ezetimibe—coronary artery disease	0.000806	0.00531	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Trandolapril—coronary artery disease	0.000788	0.00519	CcSEcCtD
Pyrimethamine—Pancytopenia—Perindopril—coronary artery disease	0.000786	0.00517	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Enalapril—coronary artery disease	0.000785	0.00517	CcSEcCtD
Pyrimethamine—Leukopenia—Acetylsalicylic acid—coronary artery disease	0.000777	0.00511	CcSEcCtD
Pyrimethamine—Erythema multiforme—Simvastatin—coronary artery disease	0.000769	0.00506	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Captopril—coronary artery disease	0.000753	0.00496	CcSEcCtD
Pyrimethamine—Haematuria—Telmisartan—coronary artery disease	0.000745	0.0049	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Perindopril—coronary artery disease	0.000731	0.00481	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Rosuvastatin—coronary artery disease	0.000714	0.0047	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Furosemide—coronary artery disease	0.000711	0.00468	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Acetylsalicylic acid—coronary artery disease	0.000708	0.00466	CcSEcCtD
Pyrimethamine—Haematuria—Perindopril—coronary artery disease	0.000703	0.00463	CcSEcCtD
Pyrimethamine—Erythema multiforme—Pravastatin—coronary artery disease	0.000695	0.00457	CcSEcCtD
Pyrimethamine—Leukopenia—Fenofibrate—coronary artery disease	0.000694	0.00457	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Acetylsalicylic acid—coronary artery disease	0.000693	0.00456	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Ramipril—coronary artery disease	0.000693	0.00456	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Losartan—coronary artery disease	0.000686	0.00451	CcSEcCtD
Pyrimethamine—Leukopenia—Clopidogrel—coronary artery disease	0.000682	0.00449	CcSEcCtD
Pyrimethamine—Leukopenia—Lovastatin—coronary artery disease	0.000677	0.00446	CcSEcCtD
Pyrimethamine—Erythema multiforme—Trandolapril—coronary artery disease	0.000675	0.00444	CcSEcCtD
Pyrimethamine—Erythema multiforme—Enalapril—coronary artery disease	0.000672	0.00442	CcSEcCtD
Pyrimethamine—Erythema multiforme—Captopril—coronary artery disease	0.000645	0.00424	CcSEcCtD
Pyrimethamine—Leukopenia—Simvastatin—coronary artery disease	0.000634	0.00417	CcSEcCtD
Pyrimethamine—Pancytopenia—Ramipril—coronary artery disease	0.000632	0.00416	CcSEcCtD
Pyrimethamine—Toxic epidermal necrolysis—Lisinopril—coronary artery disease	0.000629	0.00414	CcSEcCtD
Pyrimethamine—Erythema multiforme—Perindopril—coronary artery disease	0.000626	0.00412	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Clopidogrel—coronary artery disease	0.000622	0.00409	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Fenofibrate—coronary artery disease	0.000619	0.00408	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Lovastatin—coronary artery disease	0.000618	0.00407	CcSEcCtD
Pyrimethamine—Erythema multiforme—Furosemide—coronary artery disease	0.000609	0.00401	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ezetimibe—coronary artery disease	0.000606	0.00399	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lovastatin—coronary artery disease	0.000605	0.00398	CcSEcCtD
Pyrimethamine—Anorexia—Fenofibrate—coronary artery disease	0.000603	0.00397	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ticagrelor—coronary artery disease	0.000597	0.00393	CcSEcCtD
Pyrimethamine—Leukopenia—Olmesartan—coronary artery disease	0.000596	0.00392	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ezetimibe—coronary artery disease	0.000593	0.0039	CcSEcCtD
Pyrimethamine—Anorexia—Lovastatin—coronary artery disease	0.000589	0.00387	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Ramipril—coronary artery disease	0.000588	0.00387	CcSEcCtD
Pyrimethamine—Erythema multiforme—Losartan—coronary artery disease	0.000587	0.00386	CcSEcCtD
Pyrimethamine—Leukopenia—Niacin—coronary artery disease	0.000582	0.00383	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Simvastatin—coronary artery disease	0.000578	0.0038	CcSEcCtD
Pyrimethamine—Pancytopenia—Lisinopril—coronary artery disease	0.000573	0.00377	CcSEcCtD
Pyrimethamine—Leukopenia—Pravastatin—coronary artery disease	0.000573	0.00377	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Simvastatin—coronary artery disease	0.000566	0.00372	CcSEcCtD
Pyrimethamine—Leukopenia—Trandolapril—coronary artery disease	0.000556	0.00366	CcSEcCtD
Pyrimethamine—Leukopenia—Enalapril—coronary artery disease	0.000554	0.00365	CcSEcCtD
Pyrimethamine—Anorexia—Simvastatin—coronary artery disease	0.000551	0.00362	CcSEcCtD
Pyrimethamine—Decreased appetite—Fenofibrate—coronary artery disease	0.00055	0.00362	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Valsartan—coronary artery disease	0.000546	0.00359	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Olmesartan—coronary artery disease	0.000543	0.00357	CcSEcCtD
Pyrimethamine—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000537	0.00353	CcSEcCtD
Pyrimethamine—Decreased appetite—Lovastatin—coronary artery disease	0.000537	0.00353	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Valsartan—coronary artery disease	0.000534	0.00352	CcSEcCtD
Pyrimethamine—Stevens-Johnson syndrome—Lisinopril—coronary artery disease	0.000533	0.00351	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Olmesartan—coronary artery disease	0.000532	0.0035	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Niacin—coronary artery disease	0.000531	0.00349	CcSEcCtD
Pyrimethamine—Vomiting—Gemfibrozil—coronary artery disease	0.000527	0.00347	CcSEcCtD
Pyrimethamine—CYP2C9—heart—coronary artery disease	0.000527	0.0271	CbGeAlD
Pyrimethamine—Decreased appetite—Ezetimibe—coronary artery disease	0.000527	0.00347	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Pravastatin—coronary artery disease	0.000522	0.00344	CcSEcCtD
Pyrimethamine—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000522	0.00343	CcSEcCtD
Pyrimethamine—Anorexia—Valsartan—coronary artery disease	0.00052	0.00342	CcSEcCtD
Pyrimethamine—Anorexia—Olmesartan—coronary artery disease	0.000518	0.00341	CcSEcCtD
Pyrimethamine—Leukopenia—Perindopril—coronary artery disease	0.000516	0.0034	CcSEcCtD
Pyrimethamine—Vomiting—Ticagrelor—coronary artery disease	0.000515	0.00339	CcSEcCtD
Pyrimethamine—Haematuria—Lisinopril—coronary artery disease	0.000513	0.00338	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Pravastatin—coronary artery disease	0.000511	0.00337	CcSEcCtD
Pyrimethamine—Anorexia—Niacin—coronary artery disease	0.000506	0.00333	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Enalapril—coronary artery disease	0.000505	0.00332	CcSEcCtD
Pyrimethamine—Erythema multiforme—Ramipril—coronary artery disease	0.000504	0.00331	CcSEcCtD
Pyrimethamine—Decreased appetite—Simvastatin—coronary artery disease	0.000502	0.00331	CcSEcCtD
Pyrimethamine—Leukopenia—Furosemide—coronary artery disease	0.000502	0.0033	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Telmisartan—coronary artery disease	0.000498	0.00328	CcSEcCtD
Pyrimethamine—Anorexia—Pravastatin—coronary artery disease	0.000498	0.00328	CcSEcCtD
Pyrimethamine—CYP2C9—cardiovascular system—coronary artery disease	0.000497	0.0256	CbGeAlD
Pyrimethamine—Thrombocytopenia—Trandolapril—coronary artery disease	0.000497	0.00327	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Enalapril—coronary artery disease	0.000495	0.00326	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Telmisartan—coronary artery disease	0.000488	0.00321	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Captopril—coronary artery disease	0.000485	0.00319	CcSEcCtD
Pyrimethamine—Leukopenia—Losartan—coronary artery disease	0.000484	0.00319	CcSEcCtD
Pyrimethamine—Anorexia—Trandolapril—coronary artery disease	0.000484	0.00318	CcSEcCtD
Pyrimethamine—Anorexia—Enalapril—coronary artery disease	0.000482	0.00317	CcSEcCtD
Pyrimethamine—Anorexia—Telmisartan—coronary artery disease	0.000475	0.00313	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Captopril—coronary artery disease	0.000474	0.00312	CcSEcCtD
Pyrimethamine—Decreased appetite—Valsartan—coronary artery disease	0.000474	0.00312	CcSEcCtD
Pyrimethamine—Decreased appetite—Olmesartan—coronary artery disease	0.000472	0.00311	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Perindopril—coronary artery disease	0.00047	0.0031	CcSEcCtD
Pyrimethamine—Hypersensitivity—Fenofibrate—coronary artery disease	0.000466	0.00307	CcSEcCtD
Pyrimethamine—Anorexia—Captopril—coronary artery disease	0.000462	0.00304	CcSEcCtD
Pyrimethamine—Decreased appetite—Niacin—coronary artery disease	0.000461	0.00303	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Perindopril—coronary artery disease	0.000461	0.00303	CcSEcCtD
Pyrimethamine—Hypersensitivity—Clopidogrel—coronary artery disease	0.000458	0.00301	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Furosemide—coronary artery disease	0.000457	0.00301	CcSEcCtD
Pyrimethamine—Erythema multiforme—Lisinopril—coronary artery disease	0.000457	0.00301	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lovastatin—coronary artery disease	0.000455	0.00299	CcSEcCtD
Pyrimethamine—Decreased appetite—Pravastatin—coronary artery disease	0.000454	0.00299	CcSEcCtD
Pyrimethamine—Vomiting—Acetylsalicylic acid—coronary artery disease	0.00045	0.00296	CcSEcCtD
Pyrimethamine—Anorexia—Perindopril—coronary artery disease	0.000448	0.00295	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Furosemide—coronary artery disease	0.000448	0.00295	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ezetimibe—coronary artery disease	0.000446	0.00294	CcSEcCtD
Pyrimethamine—CYP2C8—blood—coronary artery disease	0.000443	0.0228	CbGeAlD
Pyrimethamine—Anaphylactic shock—Losartan—coronary artery disease	0.000441	0.0029	CcSEcCtD
Pyrimethamine—Decreased appetite—Trandolapril—coronary artery disease	0.000441	0.0029	CcSEcCtD
Pyrimethamine—Decreased appetite—Enalapril—coronary artery disease	0.000439	0.00289	CcSEcCtD
Pyrimethamine—Anorexia—Furosemide—coronary artery disease	0.000436	0.00287	CcSEcCtD
Pyrimethamine—Decreased appetite—Telmisartan—coronary artery disease	0.000433	0.00285	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Losartan—coronary artery disease	0.000432	0.00284	CcSEcCtD
Pyrimethamine—Hypersensitivity—Simvastatin—coronary artery disease	0.000426	0.0028	CcSEcCtD
Pyrimethamine—Decreased appetite—Captopril—coronary artery disease	0.000421	0.00277	CcSEcCtD
Pyrimethamine—Anorexia—Losartan—coronary artery disease	0.000421	0.00277	CcSEcCtD
Pyrimethamine—Leukopenia—Ramipril—coronary artery disease	0.000415	0.00273	CcSEcCtD
Pyrimethamine—Decreased appetite—Perindopril—coronary artery disease	0.000409	0.00269	CcSEcCtD
Pyrimethamine—Vomiting—Fenofibrate—coronary artery disease	0.000402	0.00265	CcSEcCtD
Pyrimethamine—Hypersensitivity—Valsartan—coronary artery disease	0.000402	0.00265	CcSEcCtD
Pyrimethamine—Decreased appetite—Furosemide—coronary artery disease	0.000398	0.00262	CcSEcCtD
Pyrimethamine—Vomiting—Clopidogrel—coronary artery disease	0.000395	0.0026	CcSEcCtD
Pyrimethamine—CYP2C9—blood—coronary artery disease	0.000393	0.0202	CbGeAlD
Pyrimethamine—Vomiting—Lovastatin—coronary artery disease	0.000393	0.00258	CcSEcCtD
Pyrimethamine—Hypersensitivity—Niacin—coronary artery disease	0.000391	0.00257	CcSEcCtD
Pyrimethamine—Vomiting—Ezetimibe—coronary artery disease	0.000385	0.00254	CcSEcCtD
Pyrimethamine—Hypersensitivity—Pravastatin—coronary artery disease	0.000385	0.00253	CcSEcCtD
Pyrimethamine—Decreased appetite—Losartan—coronary artery disease	0.000384	0.00252	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Ramipril—coronary artery disease	0.000378	0.00249	CcSEcCtD
Pyrimethamine—Vomiting—Eplerenone—coronary artery disease	0.000377	0.00248	CcSEcCtD
Pyrimethamine—Leukopenia—Lisinopril—coronary artery disease	0.000376	0.00248	CcSEcCtD
Pyrimethamine—Hypersensitivity—Trandolapril—coronary artery disease	0.000374	0.00246	CcSEcCtD
Pyrimethamine—Hypersensitivity—Enalapril—coronary artery disease	0.000372	0.00245	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Ramipril—coronary artery disease	0.00037	0.00244	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Timolol—coronary artery disease	0.00037	0.00243	CcSEcCtD
Pyrimethamine—Vomiting—Simvastatin—coronary artery disease	0.000367	0.00242	CcSEcCtD
Pyrimethamine—Hypersensitivity—Telmisartan—coronary artery disease	0.000367	0.00242	CcSEcCtD
Pyrimethamine—Anorexia—Ramipril—coronary artery disease	0.000361	0.00237	CcSEcCtD
Pyrimethamine—Anorexia—Timolol—coronary artery disease	0.000353	0.00232	CcSEcCtD
Pyrimethamine—Vomiting—Valsartan—coronary artery disease	0.000347	0.00228	CcSEcCtD
Pyrimethamine—Vomiting—Olmesartan—coronary artery disease	0.000345	0.00227	CcSEcCtD
Pyrimethamine—Anaphylactic shock—Lisinopril—coronary artery disease	0.000343	0.00226	CcSEcCtD
Pyrimethamine—Vomiting—Niacin—coronary artery disease	0.000337	0.00222	CcSEcCtD
Pyrimethamine—Hypersensitivity—Furosemide—coronary artery disease	0.000337	0.00222	CcSEcCtD
Pyrimethamine—Thrombocytopenia—Lisinopril—coronary artery disease	0.000336	0.00221	CcSEcCtD
Pyrimethamine—Vomiting—Pravastatin—coronary artery disease	0.000332	0.00219	CcSEcCtD
Pyrimethamine—Decreased appetite—Ramipril—coronary artery disease	0.000329	0.00216	CcSEcCtD
Pyrimethamine—Anorexia—Lisinopril—coronary artery disease	0.000327	0.00215	CcSEcCtD
Pyrimethamine—Hypersensitivity—Losartan—coronary artery disease	0.000325	0.00214	CcSEcCtD
Pyrimethamine—Vomiting—Trandolapril—coronary artery disease	0.000323	0.00212	CcSEcCtD
Pyrimethamine—Decreased appetite—Timolol—coronary artery disease	0.000322	0.00212	CcSEcCtD
Pyrimethamine—Vomiting—Enalapril—coronary artery disease	0.000321	0.00211	CcSEcCtD
Pyrimethamine—Vomiting—Telmisartan—coronary artery disease	0.000317	0.00209	CcSEcCtD
Pyrimethamine—Vomiting—Captopril—coronary artery disease	0.000308	0.00203	CcSEcCtD
Pyrimethamine—Vomiting—Perindopril—coronary artery disease	0.000299	0.00197	CcSEcCtD
Pyrimethamine—Decreased appetite—Lisinopril—coronary artery disease	0.000298	0.00196	CcSEcCtD
Pyrimethamine—CYP2D6—blood—coronary artery disease	0.000295	0.0152	CbGeAlD
Pyrimethamine—Vomiting—Furosemide—coronary artery disease	0.000291	0.00191	CcSEcCtD
Pyrimethamine—Vomiting—Losartan—coronary artery disease	0.000281	0.00185	CcSEcCtD
Pyrimethamine—Hypersensitivity—Ramipril—coronary artery disease	0.000279	0.00183	CcSEcCtD
Pyrimethamine—Hypersensitivity—Timolol—coronary artery disease	0.000273	0.00179	CcSEcCtD
Pyrimethamine—Hypersensitivity—Lisinopril—coronary artery disease	0.000253	0.00166	CcSEcCtD
Pyrimethamine—Vomiting—Ramipril—coronary artery disease	0.000241	0.00158	CcSEcCtD
Pyrimethamine—Vomiting—Timolol—coronary artery disease	0.000235	0.00155	CcSEcCtD
Pyrimethamine—Vomiting—Lisinopril—coronary artery disease	0.000218	0.00144	CcSEcCtD
Pyrimethamine—DHFR—Disease—JAK2—coronary artery disease	1.84e-05	0.000206	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.84e-05	0.000205	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP11B2—coronary artery disease	1.84e-05	0.000205	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—TXNRD1—coronary artery disease	1.84e-05	0.000205	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SULT1E1—coronary artery disease	1.83e-05	0.000205	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—POMC—coronary artery disease	1.82e-05	0.000204	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.82e-05	0.000203	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SULT1E1—coronary artery disease	1.81e-05	0.000203	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC22A3—coronary artery disease	1.81e-05	0.000202	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ARNTL—coronary artery disease	1.78e-05	0.000199	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HADH—coronary artery disease	1.78e-05	0.000199	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.76e-05	0.000197	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.75e-05	0.000196	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HK2—coronary artery disease	1.75e-05	0.000195	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKR1B1—coronary artery disease	1.75e-05	0.000195	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PTGS2—coronary artery disease	1.73e-05	0.000194	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKR1B1—coronary artery disease	1.73e-05	0.000193	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HK2—coronary artery disease	1.73e-05	0.000193	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.71e-05	0.000191	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA2—coronary artery disease	1.69e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G2A—coronary artery disease	1.69e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX2—coronary artery disease	1.69e-05	0.000189	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC27A1—coronary artery disease	1.67e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCG5—coronary artery disease	1.67e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HK1—coronary artery disease	1.67e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX4—coronary artery disease	1.67e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SULT1A1—coronary artery disease	1.67e-05	0.000187	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.67e-05	0.000186	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—ALB—coronary artery disease	1.66e-05	0.000186	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC27A1—coronary artery disease	1.66e-05	0.000186	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HADHA—coronary artery disease	1.65e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CPT1B—coronary artery disease	1.64e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LCAT—coronary artery disease	1.64e-05	0.000184	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTA1—coronary artery disease	1.63e-05	0.000182	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LCAT—coronary artery disease	1.63e-05	0.000182	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CPT1B—coronary artery disease	1.63e-05	0.000182	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPA—coronary artery disease	1.61e-05	0.00018	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA4—coronary artery disease	1.61e-05	0.00018	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA4—coronary artery disease	1.6e-05	0.000179	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—NOS3—coronary artery disease	1.59e-05	0.000177	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.57e-05	0.000175	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLCB3—coronary artery disease	1.56e-05	0.000175	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PDHA1—coronary artery disease	1.56e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCLM—coronary artery disease	1.56e-05	0.000174	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA5—coronary artery disease	1.55e-05	0.000173	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PDHA1—coronary artery disease	1.54e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCLM—coronary artery disease	1.54e-05	0.000172	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—P4HB—coronary artery disease	1.52e-05	0.000169	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP11B2—coronary artery disease	1.51e-05	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—TXNRD1—coronary artery disease	1.51e-05	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.5e-05	0.000168	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.5e-05	0.000167	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP11B2—coronary artery disease	1.49e-05	0.000167	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—TXNRD1—coronary artery disease	1.49e-05	0.000167	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLA2G1B—coronary artery disease	1.49e-05	0.000166	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC22A3—coronary artery disease	1.48e-05	0.000166	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC22A3—coronary artery disease	1.47e-05	0.000165	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.47e-05	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HADH—coronary artery disease	1.46e-05	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ARNTL—coronary artery disease	1.46e-05	0.000164	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.45e-05	0.000163	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PTGS2—coronary artery disease	1.45e-05	0.000162	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ARNTL—coronary artery disease	1.45e-05	0.000162	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HADH—coronary artery disease	1.45e-05	0.000162	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.43e-05	0.00016	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—VCAN—coronary artery disease	1.4e-05	0.000157	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.39e-05	0.000156	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDOA—coronary artery disease	1.39e-05	0.000156	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX2—coronary artery disease	1.39e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G2A—coronary artery disease	1.39e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA2—coronary artery disease	1.39e-05	0.000155	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA2—coronary artery disease	1.37e-05	0.000154	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX2—coronary artery disease	1.37e-05	0.000154	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	1.37e-05	0.000154	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX4—coronary artery disease	1.37e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCG5—coronary artery disease	1.37e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HK1—coronary artery disease	1.37e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SULT1A1—coronary artery disease	1.37e-05	0.000153	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCG5—coronary artery disease	1.36e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SULT1A1—coronary artery disease	1.36e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX4—coronary artery disease	1.36e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HK1—coronary artery disease	1.36e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.36e-05	0.000152	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HADHA—coronary artery disease	1.35e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—DCN—coronary artery disease	1.35e-05	0.000151	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HADHA—coronary artery disease	1.34e-05	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTA1—coronary artery disease	1.34e-05	0.00015	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTA1—coronary artery disease	1.33e-05	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPA—coronary artery disease	1.32e-05	0.000148	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALDH2—coronary artery disease	1.31e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPA—coronary artery disease	1.31e-05	0.000147	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLCB3—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3C2A—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CYP2C19—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HBA1—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LIPC—coronary artery disease	1.28e-05	0.000143	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOC3—coronary artery disease	1.27e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLCB3—coronary artery disease	1.27e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA5—coronary artery disease	1.27e-05	0.000142	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LDLR—coronary artery disease	1.26e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.26e-05	0.000141	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA5—coronary artery disease	1.26e-05	0.000141	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—TGFB1—coronary artery disease	1.25e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTT1—coronary artery disease	1.25e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SLC9A1—coronary artery disease	1.25e-05	0.00014	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—P4HB—coronary artery disease	1.24e-05	0.000139	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GCLC—coronary artery disease	1.24e-05	0.000138	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CETP—coronary artery disease	1.24e-05	0.000138	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—P4HB—coronary artery disease	1.23e-05	0.000138	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—MAPK1—coronary artery disease	1.23e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.22e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—SDC1—coronary artery disease	1.22e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLA2G1B—coronary artery disease	1.22e-05	0.000137	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.21e-05	0.000135	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.2e-05	0.000134	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.18e-05	0.000132	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMA6—coronary artery disease	1.15e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PSMB5—coronary artery disease	1.15e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.15e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—VCAN—coronary artery disease	1.15e-05	0.000129	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDOA—coronary artery disease	1.14e-05	0.000128	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—VCAN—coronary artery disease	1.14e-05	0.000128	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.13e-05	0.000127	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CTGF—coronary artery disease	1.13e-05	0.000126	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GOT2—coronary artery disease	1.12e-05	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMGCR—coronary artery disease	1.12e-05	0.000125	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—DCN—coronary artery disease	1.11e-05	0.000124	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—DCN—coronary artery disease	1.1e-05	0.000123	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALDH2—coronary artery disease	1.08e-05	0.000121	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.07e-05	0.00012	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—PIK3CA—coronary artery disease	1.07e-05	0.000119	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3C2A—coronary artery disease	1.05e-05	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LIPC—coronary artery disease	1.05e-05	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CYP2C19—coronary artery disease	1.05e-05	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HBA1—coronary artery disease	1.05e-05	0.000118	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOC3—coronary artery disease	1.04e-05	0.000117	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.04e-05	0.000117	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LIPC—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HBA1—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LDLR—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOC3—coronary artery disease	1.04e-05	0.000116	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LDLR—coronary artery disease	1.03e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.03e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PLCB1—coronary artery disease	1.03e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SLC9A1—coronary artery disease	1.03e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTT1—coronary artery disease	1.03e-05	0.000115	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.02e-05	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.02e-05	0.000114	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GCLC—coronary artery disease	1.01e-05	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CETP—coronary artery disease	1.01e-05	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.01e-05	0.000113	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GCLC—coronary artery disease	1.01e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CETP—coronary artery disease	1.01e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—SDC1—coronary artery disease	1e-05	0.000112	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ABCA1—coronary artery disease	9.96e-06	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—SDC1—coronary artery disease	9.94e-06	0.000111	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GGT1—coronary artery disease	9.64e-06	0.000108	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GOT1—coronary artery disease	9.64e-06	0.000108	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMA6—coronary artery disease	9.47e-06	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PSMB5—coronary artery disease	9.47e-06	0.000106	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—IL6—coronary artery disease	9.45e-06	0.000106	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMB5—coronary artery disease	9.39e-06	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PSMA6—coronary artery disease	9.39e-06	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	9.37e-06	0.000105	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CTGF—coronary artery disease	9.25e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CTGF—coronary artery disease	9.17e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GOT2—coronary artery disease	9.17e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMGCR—coronary artery disease	9.17e-06	0.000103	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GOT2—coronary artery disease	9.09e-06	0.000102	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMGCR—coronary artery disease	9.09e-06	0.000102	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—PIK3CA—coronary artery disease	8.93e-06	9.99e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Disease—AKT1—coronary artery disease	8.71e-06	9.74e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTP1—coronary artery disease	8.66e-06	9.68e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	8.58e-06	9.59e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—HMOX1—coronary artery disease	8.54e-06	9.55e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PLCB1—coronary artery disease	8.43e-06	9.43e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CAT—coronary artery disease	8.43e-06	9.42e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PLCB1—coronary artery disease	8.36e-06	9.35e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.2e-06	9.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOB—coronary artery disease	8.18e-06	9.15e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ABCA1—coronary artery disease	8.17e-06	9.14e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ABCA1—coronary artery disease	8.1e-06	9.06e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GSTM1—coronary artery disease	7.96e-06	8.9e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GOT1—coronary artery disease	7.92e-06	8.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GGT1—coronary artery disease	7.92e-06	8.85e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GGT1—coronary artery disease	7.85e-06	8.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GOT1—coronary artery disease	7.85e-06	8.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—LPL—coronary artery disease	7.81e-06	8.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—GPX1—coronary artery disease	7.62e-06	8.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—CD36—coronary artery disease	7.42e-06	8.3e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPP2CA—coronary artery disease	7.33e-06	8.2e-05	CbGpPWpGaD
Pyrimethamine—DHFR—Metabolism—AKT1—coronary artery disease	7.3e-06	8.16e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTP1—coronary artery disease	7.11e-06	7.95e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTP1—coronary artery disease	7.05e-06	7.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARGC1A—coronary artery disease	7.05e-06	7.88e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—MTHFR—coronary artery disease	7.03e-06	7.86e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—HMOX1—coronary artery disease	7.01e-06	7.84e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	6.98e-06	7.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—HMOX1—coronary artery disease	6.95e-06	7.77e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CAT—coronary artery disease	6.92e-06	7.74e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CAT—coronary artery disease	6.86e-06	7.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOB—coronary artery disease	6.72e-06	7.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AGT—coronary artery disease	6.68e-06	7.47e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOB—coronary artery disease	6.66e-06	7.45e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOE—coronary artery disease	6.55e-06	7.32e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GSTM1—coronary artery disease	6.53e-06	7.31e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GSTM1—coronary artery disease	6.48e-06	7.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—APOA1—coronary artery disease	6.47e-06	7.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—LPL—coronary artery disease	6.41e-06	7.17e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—LPL—coronary artery disease	6.36e-06	7.11e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—GPX1—coronary artery disease	6.26e-06	7e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—GPX1—coronary artery disease	6.2e-06	6.94e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.2e-06	6.93e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—CD36—coronary artery disease	6.09e-06	6.81e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—CD36—coronary artery disease	6.04e-06	6.75e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPP2CA—coronary artery disease	6.02e-06	6.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPP2CA—coronary artery disease	5.97e-06	6.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—MTHFR—coronary artery disease	5.78e-06	6.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—MTHFR—coronary artery disease	5.73e-06	6.4e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PPARG—coronary artery disease	5.7e-06	6.38e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—POMC—coronary artery disease	5.63e-06	6.29e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AGT—coronary artery disease	5.49e-06	6.13e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AGT—coronary artery disease	5.44e-06	6.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOE—coronary artery disease	5.38e-06	6.01e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOE—coronary artery disease	5.33e-06	5.96e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—APOA1—coronary artery disease	5.31e-06	5.94e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—APOA1—coronary artery disease	5.27e-06	5.89e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—ALB—coronary artery disease	5.13e-06	5.73e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.05e-06	5.64e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—NOS3—coronary artery disease	4.91e-06	5.49e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PPARG—coronary artery disease	4.68e-06	5.24e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PPARG—coronary artery disease	4.64e-06	5.19e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—POMC—coronary artery disease	4.62e-06	5.16e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—POMC—coronary artery disease	4.58e-06	5.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PTGS2—coronary artery disease	4.49e-06	5.02e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—ALB—coronary artery disease	4.21e-06	4.71e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—ALB—coronary artery disease	4.17e-06	4.67e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—NOS3—coronary artery disease	4.03e-06	4.5e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—NOS3—coronary artery disease	3.99e-06	4.46e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PTGS2—coronary artery disease	3.68e-06	4.12e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PTGS2—coronary artery disease	3.65e-06	4.08e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—PIK3CA—coronary artery disease	2.76e-06	3.09e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—PIK3CA—coronary artery disease	2.27e-06	2.53e-05	CbGpPWpGaD
Pyrimethamine—CYP2C8—Metabolism—AKT1—coronary artery disease	2.26e-06	2.52e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—PIK3CA—coronary artery disease	2.25e-06	2.51e-05	CbGpPWpGaD
Pyrimethamine—CYP2D6—Metabolism—AKT1—coronary artery disease	1.85e-06	2.07e-05	CbGpPWpGaD
Pyrimethamine—CYP2C9—Metabolism—AKT1—coronary artery disease	1.84e-06	2.05e-05	CbGpPWpGaD
